Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B B Hasinoff

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Journal of Chromatography. B, Biomedical Sciences and Applications|September 4, 2001
High-throughput fluorescence flow-injection topoisomerase II inhibition assayN Barnabé, B B Hasinoff
Biochimica Et Biophysica Acta|March 30, 1983
Pulse radiolysis kinetics of the reaction of hydrated electrons with ferric-, ferrous-, protoporphyrin IX- and apo-myoglobinB B Hasinoff, I Pecht
Journal of Inorganic Biochemistry|October 1, 1986
On the rates of enzymatic, protein and model compound reactions: the importance of diffusion controlH B Dunford, B B Hasinoff
Agents and Actions|May 1, 1993
The removal of metal ions from transferrin, ferritin and ceruloplasmin by the cardioprotective agent ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] and its hydrolysis product ADR-925B B Hasinoff, S V Kala
Archives of Biochemistry and Biophysics|February 1, 1995
Doxorubicin reduces the iron(III) complexes of the hydrolysis products of the antioxidant cardioprotective agent dexrazoxane (ICRF-187) and produces hydroxyl radicalsK L Malisza, B B Hasinoff
British Journal of Clinical Pharmacology|March 1, 1991
Iron supplements: a common cause of drug interactionsN R Campbell, B B Hasinoff
Agents and Actions|September 1, 1993
The one-ring open hydrolysis product intermediates of the cardioprotective agent ICRF-187 (dexrazoxane) displace iron from iron-anthracycline complexesJ L Buss, B B Hasinoff
Biochemical Pharmacology|October 1, 1988
Adriamycin and its iron(III) and copper(II) complexes. Glutathione-induced dissociation; cytochrome c oxidase inactivation and protection; binding to cardiolipinB B Hasinoff, J P Davey
Redox Report : Communications in Free Radical Research|July 15, 2016
Hydroxyl radical production by the iron complex of the hydrolysis product of the antioxidant cardioprotective agent ICRF-187 (dexrazoxane)K L Malisza, B B Hasinoff
Journal of Inorganic Biochemistry|January 22, 2000
The displacement of iron(III) from its complexes with the anticancer drugs piroxantrone and losoxantrone by the hydrolyzed form of the cardioprotective agent dexrazoxaneB B Hasinoff, K T Tran
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Journal of Chromatography. B, Biomedical Sciences and Applications|September 4, 2001
High-throughput fluorescence flow-injection topoisomerase II inhibition assayN Barnabé, B B Hasinoff
Biochimica Et Biophysica Acta|March 30, 1983
Pulse radiolysis kinetics of the reaction of hydrated electrons with ferric-, ferrous-, protoporphyrin IX- and apo-myoglobinB B Hasinoff, I Pecht
Journal of Inorganic Biochemistry|October 1, 1986
On the rates of enzymatic, protein and model compound reactions: the importance of diffusion controlH B Dunford, B B Hasinoff
Agents and Actions|May 1, 1993
The removal of metal ions from transferrin, ferritin and ceruloplasmin by the cardioprotective agent ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] and its hydrolysis product ADR-925B B Hasinoff, S V Kala
Archives of Biochemistry and Biophysics|February 1, 1995
Doxorubicin reduces the iron(III) complexes of the hydrolysis products of the antioxidant cardioprotective agent dexrazoxane (ICRF-187) and produces hydroxyl radicalsK L Malisza, B B Hasinoff
British Journal of Clinical Pharmacology|March 1, 1991
Iron supplements: a common cause of drug interactionsN R Campbell, B B Hasinoff
Agents and Actions|September 1, 1993
The one-ring open hydrolysis product intermediates of the cardioprotective agent ICRF-187 (dexrazoxane) displace iron from iron-anthracycline complexesJ L Buss, B B Hasinoff
Biochemical Pharmacology|October 1, 1988
Adriamycin and its iron(III) and copper(II) complexes. Glutathione-induced dissociation; cytochrome c oxidase inactivation and protection; binding to cardiolipinB B Hasinoff, J P Davey
Redox Report : Communications in Free Radical Research|July 15, 2016
Hydroxyl radical production by the iron complex of the hydrolysis product of the antioxidant cardioprotective agent ICRF-187 (dexrazoxane)K L Malisza, B B Hasinoff
Journal of Inorganic Biochemistry|January 22, 2000
The displacement of iron(III) from its complexes with the anticancer drugs piroxantrone and losoxantrone by the hydrolyzed form of the cardioprotective agent dexrazoxaneB B Hasinoff, K T Tran
Pageof 9